Company intelligence / Profile preview

Jiangsu Jibeier Pharmaceutical

Ownership: Private
Employees: ~1327
Development stage: Commercial

Overview

Jiangsu Jibeier Pharmaceutical is a China-based pharmaceutical company focused on the research, development, production, and sales of drugs. It has a diverse portfolio including tablets, capsules, eye drops, ointments, gels and specializes in small molecules and liposomal formulations. The company’s products are used for indications such as hypertension, leukopenia/thrombocytopenia, bronchitis, osteoarthritis and eye infections. Several products are approved in China; the company also holds multiple invention patents and new drug certificates.

Therapeutic areas: PulmonologyHematologyCardiovascularInfectious Diseases
Modalities: Small moleculeLiposomal drug
Industry: Biotech

Drug pipeline

7 assets

JJH201701

Preclinical

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Jiangsu Jibeier Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Jibeier Pharmaceutical.

Explore the full profile